Follow
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed on November 16, 2020 through the merger of Mylan and Upzone, a legacy division of Pfizer.
The corporation’s name derives from the Latin words via, meaning path, and tris, meaning three, denoting the course of the three main objectives set by the corporation. Viatris is ranked 254th on the 2021 Fortune 500 ranking of the largest United States corporations based on its 2020 total revenue.
On November 16, 2020, Upjohn merged with Mylan in a reverse Morris Trust transaction and was renamed Viatris. At that time, Michael Gottler became the chief executive officer.
Following the merger, the company began trading on the NASDAQ using the ticker symbol VTRS. In December 2020, the company announced a cost-cutting restructuring plan that would affect up to 20% of its global workforce, or 9,000 jobs at its facilities around the world.
In 2021, Viatris was ranked 5th by Fortune on its annual “Change the World” list. In February 2022, Viatris announced an agreement in which it would contribute Biocon Biologics’ biosimilar portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including at least a 12.9% stake in Biocon Biologics.
